Illinois Law welcomes five new faculty hires

The University of Illinois College of Law is thrilled to welcome five new faculty members to our roster this fall.  

Sara Gerke joins Illinois as an Associate Professor of Law and Richard W. & Marie L. Corman Scholar. Her research focuses on the ethical and legal challenges of artificial intelligence and big data for health care and health law in the United States and Europe. She also researches comparative law and ethics of other issues at the cutting edge of medical developments, such as the clinical translation of stem cell research, biological products, such as somatic cells, tissues, and gene therapy, reproductive medicine, such as mitochondrial replacement techniques, and digital health more generally. Professor Gerke has over 60 publications in health law and bioethics, and her work has appeared in leading law, medical, scientific, and bioethics journals. Professor Gerke earned a JD from University of Augsburg and an MA from King’s College London.  

Bill Watson joins Illinois as an Assistant Professor of Law. His work has focused on the intersection of public law and philosophy and has appeared or is forthcoming in law reviews like the Northwestern University Law Review and Boston University Law Review, as well as peer-reviewed journals like Law and Philosophy and Legal Theory. He is currently working on projects that address originalism in constitutional interpretation, the import of legal positivism for legal interpretation, and the U.S. Supreme Court’s recent treatment of precedent. Professor Watson received his JD from the University of Chicago Law School and his PhD in Philosophy from Cornell University. He was a Climenko Fellow and Lecturer on Law at Harvard Law School immediately prior to joining the University of Illinois faculty. 

Jingkang (Jake) Gao joins Illinois as a Visiting Assistant Professor of Law. In his work, he has explored how legal institutions can make urban mobility safer, cleaner, more accessible, and more equitable, and how insights from urban mobility can enrich the study of law. He has applied his background in law in his work with the Chicago Transit Authority on facilitating bus electrification and cultivating a healthier electric bus market in the United States. Professor Gao earned his JD from Columbia Law School and his PhD and an MS from the Massachusetts Institute of Technology.

Maxim Krupskiy joins Illinois as a Visiting Scholar, as part of the Illinois Scholars at Risk program. He has more than twelve years of experience practicing law in Russia defending refugees and civil activists and, as an independent expert, has prepared more than forty independent anti-corruption expert opinions. Krupskiy recently spent time as a Visiting Scholar at the Fletcher School of Law and Diplomacy at Tufts University and a Non-Resident Fellow at the George Washington University, Russia Program.   

Benjamin Horton joins Illinois as a Visiting Lecturer in Law and Stanton Fellow with our First Amendment Clinic. He was inspired to pursue a legal education during the 2016 presidential election and focused his education on free expression and election issues, participating in several clinics and interning for the Center for Democracy and Technology. After completing his JD at Harvard Law School, Horton spent a year with Free Speech For People, an election litigation nonprofit, and two years clerking in the District of Massachusetts. 

The College of Law is proud to have these individuals joining our faculty and looks forward to their accomplishments as part of the University of Illinois.

Sherkow receives prestigious recognition as University Scholar

Professor Jacob Sherkow is one of only five University of Illinois Urbana-Champaign professors to be named a University Scholar in recognition of his excellence in teaching, scholarship and service. 

The scholars program recognizes faculty excellence and provides $15,000 to each scholar for three years to enhance their academic careers. The money may be used for travel, equipment, research assistants, books or other purposes.

“The University Scholars program celebrates the remarkable achievements of the named individuals,” said Nicholas Jones, the University of Illinois System’s executive vice president and vice president for academic affairs. “Our faculty represent the strong foundation of the world-class academic experience that contributes to the betterment of society and draws students and researchers to the U. of I. System universities from across the globe. The University Scholars are exemplars of that faculty excellence. 

“When you consider the diversity of scholarship across all three of our universities and the standards of academic excellence that we nurture and grow through our recruitment of esteemed educators and researchers, all of our University Scholar recipients should be deservedly proud of the honor.”

Sherkow publishes chapter in COVID-19 and the Law

Professor Jacob Sherkow is one of the authors of a chapter in the new book “COVID-19 and the Law,” published by Cambridge University Press. The chapter examines the ways in which aspects of health law such as food and drug regulation, healthcare reimbursement, and direct research and development subsidies encouraged and impeded new technologies in the fight against COVID-19. The authors sought to provide insight to highlight important lessons for policymakers in order to better prepare for the next pandemic.

Politico quotes Sherkow on CRISPR case

The dispute over who invented CRISPR-Cas9 gene editing is headed to federal appellate court, and Politico turned to Professor Jacob Sherkow to help sort out the details. He expects the case will return to patent court and may result in changes to the licensing fees collected. “Absolutely none of this under any reasonable interpretation is going to change what the retail sticker cost of these drug therapies are going to be — not by a dollar, not by a cent,” Sherkow added.

Sherkow is quoted in Nature Biotechnology about prime editing and patents

Illinois Law professor and IP expert Jacob Sherkow spoke to Nature Biotechnology about the recent Tome Biosciences acquisition of Replace Therapeutics to enhance their gene editing capabilities. The article discusses the surge of prime editing deals in biotechnology as companies seek to secure patent rights and avoid intellectual property conflicts. The industry is seeing mergers and partnerships driven by the need for access to patented technologies. Sherkow highlighted the importance of IP rights in these deals, stating, “It is an absolute gobsmacking sum of money. And that is something that is worth thinking about as to whether or not that is a lesson for others in the field.”

College of Law honors J. Ross and Sherkow with 2024 awards for scholarly excellence

Professor Jacqueline E. Ross was awarded the 2024 Wayne R. LaFave Award for Scholarly Excellence for her book “Making Sense of Youth Crime: A Comparison of Police Intelligence in the United States and France,” (Cambridge University Press, 2023) co-authored with Thierry Delpeuch of the French National Centre for Scientific Research. This award was established in 2002 by Michael Moore, the Charles R. Walgreen, Jr. Chair, and Heidi Hurd, the Ross and Helen Workman Chair in Law. The award was established in honor of Professor Wayne LaFave, whose remarkable scholarly legacy in criminal law and procedure is best honored through the recognition of work that is of matching ambition and importance.

Professor Jacob S. Sherkow was awarded the 2024 Carroll P. Hurd Award for Scholarly Excellence for his article “The Antibody Patent Paradox,” Yale Law Journal (2023), co-authored with Mark Lemley of Stanford Law School. The Carroll P. Hurd Award for Scholarly Excellence was established in 2002, also by Michael Moore and Heidi Hurd, in honor of Carroll Parsons Hurd, whose work as a political theorist and lawyer elevated theoretical curiosity and intellectual rigor above all other virtues.

New paper from Sherkow available for download

The famous system of breaking down legal analyses into ordered subparts, Issue-Rule-Analysis-Conclusion, needs an updated focus on the last part, according to Professor Jacob Sherkow. In his new paper, available for download on SSRN, he argues that lawyers need to be experts in conclusions, writing “good conclusions – clear, reasonable, workable, plausible, probable conclusions – are the product of a variety of skills one hopes law students develop during their studies, including case synthesis as tested by the IRAC method and its siblings.” 

Sherkow speaks at workshop in Tasmania

Professor Jacob Sherkow was invited to speak at the “Regulation of Innovative Health Technologies Workshop,” which took place at the leading Centre for Law and Genetics, University of Tasmania, from November 23-25, 2023. As part of the workshop, Sherkow was the organizer of a session examining patents as regulators of innovative health technologies. The international workshop was attended by leading global health regulation and intellectual property rights scholars to discuss issues at the cutting edge of how we develop, regulate and deliver access to innovative health technologies.

Approval of CRISPR therapy may soon lead to lawsuits according to Sherkow

“I would be surprised, bluntly, if [a lawsuit] does not get filed by the end of this year,” Professor Jacob Sherkow told Politico about the patent battle over CRISPR technology. When the FDA issued approval for the therapy in sickle cell cases, it granted approval to companies that do not hold licenses for CRISPR. As Sherkow explained, the Broad Institute holds the U.S. patent on editing human cells with CRISPR and can sue companies that don’t have licenses for their patents for infringement as soon as a new product comes on the market, which is certain to happen following FDA approval. 

MIT Technology Review quotes Sherkow on CRISPR sickle cell treatment

Approval for Vertex Pharmaceutical’s sickle cell treatment using CRISPR technology has brought use of the gene-editing therapy to a “collision point,” according to Professor Jacob Sherkow. Speaking to the MIT Technology Review, Sherkow explained how the patent on editing human cells using CRISPR is owned by the Broad Institute of MIT and Harvard, not Vertex, which will almost certainly result in a lawsuit. With a potential market in the tens of billions, Sherkow believes a lawsuit is inevitable.

College of Law
504 East Pennsylvania Avenue
Champaign, IL 61820
(217) 333-0931